10x Insights
Loading account…
Companies / Health Care / Mesa Laboratories, Inc.
MLAB

Mesa Laboratories, Inc.

Health CareMedical Instruments
Ticker MLABLAKEWOOD, COFiscal year ends MarchBook value per share $32.79Diluted shares 5.8M

Mesa Laboratories, Inc. (Nasdaq: MLAB) designs and manufactures life sciences tools and quality-control products and services for regulated pharmaceutical, healthcare, and medical-device applications. Its customers include manufacturers, hospitals, dental offices, clinical research laboratories, contract research… From the company’s description.

Over the twelve months to Jun 30, 2026, Mesa Laboratories, Inc. reported revenue of $249.72M, up 3.0% from a year earlier, and net income of $4.80M. Its operating margin was 9.0%, and operations generated $55.67M in cash. In fiscal 2025, it reported revenue of $249.13M, up 3.4% from fiscal 2024, and net income of $6.71M.

Fiscal year 2025 · ends 03-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$249.13MFY2025
+3.4% year over year
Last 12 mo $249.72M
7.43%FY2025
+0.7 percentage points
Last 12 mo 9.00%
$6.71MFY2025
+440.0% year over year
Last 12 mo $4.80M
3.60%FY2025
+4.8 percentage points
Last 12 mo 2.54%
Cash & financing
$42.83MFY2025
−8.5% year over year
Last 12 mo $55.67M
$39.58MFY2025
−7.0% year over year
Last 12 mo $52.87M
0.81FY2025
Was 1.11× a year earlier
Last 12 mo 0.76
5.6MFY2025
+2.7% year over year
Last 12 mo 5.8M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Mesa Laboratories, Inc. does

In the company’s own words

Mesa Laboratories, Inc. (Nasdaq: MLAB) designs and manufactures life sciences tools and quality-control products and services for regulated pharmaceutical, healthcare, and medical-device applications. Its customers include manufacturers, hospitals, dental offices, clinical research laboratories, contract research organizations, biopharmaceutical companies, academic laboratories, and dialysis providers. Mesa reports four divisions: Sterilization and Disinfection Control, which supplies biological, chemical, and cleaning indicators and sterility-assurance testing; Clinical Genomics, which sells genetic-analysis instruments, consumables, and services, including its MassARRAY® platform; Biopharmaceutical Development, which provides protein-analysis and peptide-synthesis systems, consumables, and support; and Calibration Solutions, which offers calibration instruments, renal-care meters and consumables, and environmental monitoring systems. Its brands include Apex®, EZTest®, MassARRAY®, Gyrolab®, PurePep®, DialyGuard®, DryCal®, DataTrace®, and ViewPoint®. Mesa’s products and services reach customers through direct sales teams and independent distributors, with manufacturing operations in the United States and Europe. As of March 31, 2026, it had 717 employees. Its website is www.mesalabs.com.

Company details
Sector
Health Care
Industry (SIC)
Medical Instruments
Headquarters
LAKEWOOD, CO
Fiscal year end
March
CIK
724004
SIC
3823

Financial performance, year by year

Fiscal 2011–2025 · USD
$-304.64M$-153.45M$-2.26M$148.93M$300.12M201120122013201420152016201720182019202020212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Mesa Laboratories, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

185
funds hold it
0 of 35
superinvestors hold it
$179.42M
held by funds, at market
32.0%
of shares held by funds

Largest fund holders · Mesa Laboratories, Inc.’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.02%of fund net assets
DIAMOND HILL SMALL CAP FUND
DHSCX · Diamond Hill Funds
3.54%of fund net assets
Column Small Cap Select Fund
CFSSX · Trust for Professional Managers
—of fund net assets
Fidelity Enhanced Small Cap Core ETF
FESM · Fidelity Covington Trust
0.13%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Mesa Laboratories, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Mesa Laboratories, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Mesa Laboratories, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.